Groupe la Francaise
PFE icon

Groupe la Francaise’s Pfizer PFE Stock Holding History

Groupe la Francaise’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$903K Buy
37,500
+500
+1% +$13.1K 0.01% 283
2026
Q1 		$1.04M Hold
37,000
– – 0.01% 277
2025
Q4 		$921K Buy
37,000
+22,000
+147% +$555K 0.01% 275
2025
Q3 		$382K Hold
15,000
– – 0.01% 374
2025
Q2 		$364K Buy
+15,000
New +$350K 0.01% 341

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Groupe la Francaise's PFE Position: Q2 2026 in Review

Groupe la Francaise reduced its Pfizer (PFE) stake by 11% in Q2 2026, selling an estimated $54.2K and leaving 16,100 shares worth $367K. The position accounts for ﹤0.01% of the portfolio, ranked #365.

Groupe la Francaise first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.97M in Q1 2025. 2,843 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Groupe la Francaise held 16,100 shares of Pfizer worth $367K as of Q2 2026.
  • Groupe la Francaise sold 2,073 Pfizer shares in Q2 2026, an estimated $54.2K.
  • Pfizer made up ﹤0.01% of Groupe la Francaise's portfolio in Q2 2026, its #365 holding.
  • Groupe la Francaise first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Groupe la Francaise's Pfizer position peaked at $3.97M in Q1 2025.
  • 2,843 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.